Label Value
DOI 10.1186/s12885-016-2440-9
TITLE Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program
TYPE article
Service Status Date Last Checked
Scopus Yes 2017-01-11T15:46:53.514599+00:00
Web of Science Yes 2018-04-08T17:25:33.352608
Compendex No 2020-10-15T19:31:48.115895